The new reality of investing (2024 edition)

Equity analyst Laura Nelson Carney uses her PhD in neuroscience to help spot medical innovation around the world. She brings a deep understanding of science to health care investing, using her research and drug development experience to help identify breakthrough drugs. And today ...  Show more

Brittain Ezzes, a portfolio manager for Capital Group Dividend Value ETF, shares her perspective on an unexpected rally this year among heavy-asset companies, or companies outside of AI and big tech. She offers three catalysts that could sustain the rally, identifies areas where ...  Show more

Welcome back to the Wise Investor Segment, where we delve deep into the world of real estate investment to uncover the latest trends and challenges facing investors.

In this episode, we explore the dynamic landscape of real estate investing in the current year. From shi ...

The 28th annual edition of our 2024 Long-Term Capital Market Assumptions explores how investors can build on the 60/40 portfolio – using new axes of diversification to navigate an economy in transition from disinflation to reflation and from easy monetary policy to higher costs o ...  Show more

Why investing in non-investment grade bonds, leveraged loans, and preferred stocks is potentially more compelling than investing in common stocks at present.

Topics covered include:

As we get into the new year, we discuss how we’re setting up our portfolios and what we’re investing in for the year ahead. In this episode we:Discuss our financial goals for the year aheadUnpack the concept of Core and Satellite portfolioShare the ETFs we’re buying Show how we’r ...  Show more